| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | SIN3B NCOA6 HNF1A TCF3 ARID3A ERG CENPB POU1F1 SIN3A JMJD1C NFATC3 ATXN7 GLI2 TLE1 RERE EP300 CRAMP1 NOTCH1 BAHCC1 FOXC2 | 7.94e-06 | 739 | 175 | 20 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | TFEC HNF1A TCF3 ERG POU1F1 BSX SALL2 HOXD8 NFATC3 GLI2 NOTCH1 NOTCH4 ZNF574 ZNF292 FOXJ1 FOXC2 | 3.54e-05 | 560 | 175 | 16 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | TFEC HNF1A TCF3 ERG POU1F1 BSX SALL2 HOXD8 NFATC3 GLI2 NOTCH1 NOTCH4 ZNF574 ZNF292 FOXJ1 FOXC2 | 4.02e-05 | 566 | 175 | 16 | GO:0001216 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX5 TFEC KLF12 HNF1A TCF3 ERG ADNP2 POU1F1 ZNF280B BCL11A BSX AHRR SALL2 HOXD8 NFATC3 GLI2 NTN1 RORC EMX1 EN1 NOTCH1 NOTCH4 ZNF574 ZNF292 FOXJ1 FOXC2 | 2.53e-04 | 1412 | 175 | 26 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX5 TFEC KLF12 HNF1A TCF3 ERG POU1F1 ZNF280B BCL11A BSX SALL2 NFATC3 GLI2 NLRC5 NTN1 RORC EMX1 EN1 EP300 NOTCH1 NOTCH4 ZNF574 FOXJ1 FOXC2 | 3.11e-04 | 1271 | 175 | 24 | GO:0000987 |
| GeneOntologyMolecularFunction | transcription coregulator activity | SIN3B NCOA6 DCAF6 TRIM25 ARID3A MAML1 SIN3A BCL11A KMT2E JMJD1C TLE1 RERE EP300 NOTCH1 | 4.48e-04 | 562 | 175 | 14 | GO:0003712 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | CLSTN3 SYT3 SIN3A BCL11A MST1 CDKL5 SEMA5B ROBO1 MACF1 NTN1 MST1L EMX1 EP300 NOTCH1 | 2.81e-07 | 299 | 175 | 14 | GO:0060560 |
| GeneOntologyBiologicalProcess | cell morphogenesis | WHRN FLNB CLSTN3 SYT3 SZT2 CNTNAP1 FRYL SIN3A BCL11A JMJD1C FAM171A1 CDKL5 ABLIM1 CLIC5 SEMA5B PTPRZ1 GLI2 SH3D19 LRP2 ROBO1 MACF1 DLG4 NTN1 RERE EMX1 EP300 NOTCH1 CDH15 NOTCH4 | 2.83e-07 | 1194 | 175 | 29 | GO:0000902 |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 1.29e-06 | 65 | 175 | 7 | GO:0060443 | |
| GeneOntologyBiologicalProcess | neuron projection extension | CLSTN3 SYT3 SIN3A BCL11A CDKL5 SEMA5B ROBO1 MACF1 NTN1 EMX1 EP300 | 1.63e-06 | 207 | 175 | 11 | GO:1990138 |
| GeneOntologyBiologicalProcess | neuron development | WHRN CLSTN3 SYT3 SZT2 CNTNAP1 KATNB1 NCKIPSD FRYL SIN3A BCL11A WNK1 CDKL5 ABLIM1 CLIC5 ALMS1 TENM3 SEMA5B PTPRZ1 GLI2 CSPG4 LRP2 ROBO1 MACF1 DLG4 NTN1 RERE EMX1 EN1 EP300 NOTCH1 HTT | 1.95e-06 | 1463 | 175 | 31 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | PRKD2 TFEC NCOA6 KLF12 HNF1A TCF3 DCAF6 ARID3A ERG MAML1 POU1F1 BSX TFR2 ABLIM1 PRDM10 SALL2 HOXD8 NFATC3 ATXN7 GLI2 NLRC5 LRP5 EN1 EP300 NOTCH1 NOTCH4 ZNF574 ZNF292 FOXJ1 FOXC2 | 2.03e-06 | 1390 | 175 | 30 | GO:0045944 |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 2.12e-06 | 45 | 175 | 6 | GO:0060603 | |
| GeneOntologyBiologicalProcess | neuron projection development | WHRN CLSTN3 SYT3 SZT2 CNTNAP1 KATNB1 NCKIPSD FRYL SIN3A BCL11A CDKL5 ABLIM1 CLIC5 ALMS1 TENM3 SEMA5B PTPRZ1 GLI2 CSPG4 LRP2 ROBO1 MACF1 DLG4 NTN1 RERE EMX1 EP300 NOTCH1 | 3.90e-06 | 1285 | 175 | 28 | GO:0031175 |
| GeneOntologyBiologicalProcess | embryo development | SOX5 WHRN NCOA6 HNF1A TCF3 AFF3 SIN3A WNK1 BIRC6 SEC24D SALL2 CLIC5 HOXD8 AMOT GLI2 RBPMS2 LRP2 FLCN LRP5 UBR3 MACF1 DLG4 NTN1 EMX1 EN1 PCDH8 EP300 NOTCH1 HTT FOXC2 | 3.96e-06 | 1437 | 175 | 30 | GO:0009790 |
| GeneOntologyBiologicalProcess | mammary gland development | 1.03e-05 | 162 | 175 | 9 | GO:0030879 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CLSTN3 SYT3 SZT2 CNTNAP1 SIN3A BCL11A CDKL5 ABLIM1 SEMA5B PTPRZ1 GLI2 LRP2 ROBO1 MACF1 DLG4 NTN1 RERE EMX1 EP300 NOTCH1 | 1.63e-05 | 802 | 175 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 2.05e-05 | 7 | 175 | 3 | GO:0007221 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | WHRN SZT2 CNTNAP1 SIN3A BCL11A CDKL5 ABLIM1 CLIC5 SEMA5B PTPRZ1 GLI2 LRP2 ROBO1 MACF1 DLG4 NTN1 RERE EP300 NOTCH1 | 2.09e-05 | 748 | 175 | 19 | GO:0048667 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CLSTN3 SYT3 SZT2 CNTNAP1 SIN3A BCL11A CDKL5 ABLIM1 SEMA5B PTPRZ1 GLI2 LRP2 ROBO1 MACF1 DLG4 NTN1 RERE EMX1 EP300 NOTCH1 | 2.20e-05 | 819 | 175 | 20 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CLSTN3 SYT3 SZT2 CNTNAP1 SIN3A BCL11A CDKL5 ABLIM1 SEMA5B PTPRZ1 GLI2 LRP2 ROBO1 MACF1 DLG4 NTN1 RERE EMX1 EP300 NOTCH1 | 2.49e-05 | 826 | 175 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | WHRN HNF1A TCF3 AFF3 WNK1 CLIC5 AMOT GLI2 RBPMS2 LRP2 LRP5 MACF1 NTN1 EN1 PCDH8 NOTCH1 HTT FOXC2 | 3.78e-05 | 713 | 175 | 18 | GO:0048598 |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 4.86e-05 | 9 | 175 | 3 | GO:1905653 | |
| GeneOntologyBiologicalProcess | mammary duct terminal end bud growth | 4.86e-05 | 9 | 175 | 3 | GO:0060763 | |
| GeneOntologyBiologicalProcess | paraxial mesoderm formation | 4.86e-05 | 9 | 175 | 3 | GO:0048341 | |
| GeneOntologyBiologicalProcess | developmental cell growth | CLSTN3 SYT3 SIN3A BCL11A CDKL5 SEMA5B ROBO1 MACF1 NTN1 EMX1 EP300 | 5.49e-05 | 301 | 175 | 11 | GO:0048588 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SOX5 WHRN HNF1A XIRP1 SCHIP1 BSX MST1 ABLIM1 CLIC5 ALMS1 HOXD8 TENM3 GLI2 TLE1 RBPMS2 LRP2 LRP5 ROBO1 NTN1 MST1L EMX1 EP300 NOTCH1 HTT FOXC2 | 7.19e-05 | 1269 | 175 | 25 | GO:0009887 |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 8.05e-05 | 84 | 175 | 6 | GO:0061180 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SIN3B TFEC KLF12 HNF1A TCF3 POU1F1 SIN3A BCL11A AHRR SALL2 HOXD8 NFATC3 GLI2 TLE1 FLCN RORC EN1 EP300 NOTCH1 NOTCH4 FOXJ1 FOXC2 | 8.76e-05 | 1053 | 175 | 22 | GO:0000122 |
| GeneOntologyBiologicalProcess | developmental growth | CLSTN3 XIRP1 SYT3 POU1F1 SIN3A BCL11A MST1 CDKL5 ALMS1 SEMA5B GLI2 ROBO1 MACF1 NTN1 MST1L EMX1 EN1 EP300 NOTCH1 FOXC2 | 9.66e-05 | 911 | 175 | 20 | GO:0048589 |
| GeneOntologyBiologicalProcess | axonogenesis | SZT2 CNTNAP1 SIN3A BCL11A CDKL5 ABLIM1 SEMA5B PTPRZ1 GLI2 LRP2 ROBO1 MACF1 NTN1 EP300 NOTCH1 | 1.01e-04 | 566 | 175 | 15 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of oligodendrocyte progenitor proliferation | 1.25e-04 | 12 | 175 | 3 | GO:0070445 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.43e-04 | 178 | 175 | 8 | GO:0022612 | |
| GeneOntologyBiologicalProcess | oligodendrocyte progenitor proliferation | 1.61e-04 | 13 | 175 | 3 | GO:0070444 | |
| GeneOntologyBiologicalProcess | paraxial mesoderm morphogenesis | 1.61e-04 | 13 | 175 | 3 | GO:0048340 | |
| GeneOntologyBiologicalProcess | pattern specification process | HOXD8 GLI2 LRP2 LRP5 ROBO1 EMX1 EN1 PCDH8 EP300 CRAMP1 NOTCH1 HTT FOXJ1 FOXC2 | 1.65e-04 | 526 | 175 | 14 | GO:0007389 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.01e-04 | 187 | 175 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | paranodal junction maintenance | 2.14e-04 | 3 | 175 | 2 | GO:1990227 | |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 2.27e-04 | 65 | 175 | 5 | GO:0072132 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | PRKD2 HNF1A MST1 ALMS1 NFATC3 GLI2 LRP2 LRP5 ROBO1 MACF1 NTN1 MST1L PCDH8 NOTCH1 NOTCH4 HTT FOXC2 | 2.28e-04 | 750 | 175 | 17 | GO:0048729 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | BCL11A CDKL5 ARRB2 PTPRZ1 LRP2 ROBO1 MACF1 DLG4 NTN1 EP300 NOTCH1 | 2.28e-04 | 354 | 175 | 11 | GO:0050769 |
| GeneOntologyBiologicalProcess | regionalization | HOXD8 GLI2 LRP2 LRP5 ROBO1 EMX1 EN1 PCDH8 EP300 NOTCH1 HTT FOXJ1 FOXC2 | 2.31e-04 | 478 | 175 | 13 | GO:0003002 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | CLSTN3 BCL11A CDKL5 ARRB2 PTPRZ1 LRP2 ROBO1 MACF1 DLG4 NTN1 EP300 NOTCH1 | 2.46e-04 | 418 | 175 | 12 | GO:0051962 |
| GeneOntologyBiologicalProcess | rRNA catabolic process | 2.53e-04 | 15 | 175 | 3 | GO:0016075 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | SOX5 NCOA6 HNF1A SIN3A BIRC6 SEC24D SALL2 AMOT GLI2 LRP2 FLCN UBR3 EMX1 EN1 PCDH8 EP300 NOTCH1 HTT FOXC2 | 2.61e-04 | 906 | 175 | 19 | GO:0043009 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | PRKD2 MST1 NFATC3 GLI2 LRP2 LRP5 ROBO1 NTN1 MST1L NOTCH1 NOTCH4 FOXC2 | 2.63e-04 | 421 | 175 | 12 | GO:0060562 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | PRKD2 MST1 ALMS1 NFATC3 GLI2 LRP2 LRP5 ROBO1 NTN1 MST1L PCDH8 NOTCH1 NOTCH4 HTT FOXC2 | 2.67e-04 | 619 | 175 | 15 | GO:0002009 |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 2.69e-04 | 247 | 175 | 9 | GO:0009952 | |
| GeneOntologyBiologicalProcess | gland development | HNF1A ACO2 POU1F1 BSX MST1 FASN NFATC3 GLI2 LRP5 ROBO1 NTN1 MST1L NOTCH1 NOTCH4 | 3.02e-04 | 558 | 175 | 14 | GO:0048732 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | SOX5 NCOA6 HNF1A SIN3A BIRC6 SEC24D SALL2 AMOT GLI2 LRP2 FLCN UBR3 EMX1 EN1 PCDH8 EP300 NOTCH1 HTT FOXC2 | 3.56e-04 | 929 | 175 | 19 | GO:0009792 |
| GeneOntologyBiologicalProcess | regulation of artery morphogenesis | 3.74e-04 | 17 | 175 | 3 | GO:1905651 | |
| GeneOntologyBiologicalProcess | axon development | SZT2 CNTNAP1 SIN3A BCL11A CDKL5 ABLIM1 SEMA5B PTPRZ1 GLI2 LRP2 ROBO1 MACF1 NTN1 EP300 NOTCH1 | 3.92e-04 | 642 | 175 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | cilium assembly | DNAH1 CEP350 EVI5 CDKL5 PTPDC1 ABLIM1 ALMS1 TBC1D22A DNAH8 NOTCH1 HTT FOXJ1 | 4.25e-04 | 444 | 175 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 4.25e-04 | 4 | 175 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | glomerular mesangial cell development | 4.25e-04 | 4 | 175 | 2 | GO:0072144 | |
| GeneOntologyBiologicalProcess | glomerular mesangial cell differentiation | 4.25e-04 | 4 | 175 | 2 | GO:0072008 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 4.28e-04 | 114 | 175 | 6 | GO:0050772 | |
| GeneOntologyBiologicalProcess | gastrulation | 4.67e-04 | 212 | 175 | 8 | GO:0007369 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | DNAH1 CEP350 EVI5 CDKL5 PTPDC1 ABLIM1 ALMS1 TBC1D22A CSPG4 HRG NTN1 DNAH8 NOTCH1 HTT FOXJ1 | 6.09e-04 | 670 | 175 | 15 | GO:0120031 |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 6.14e-04 | 122 | 175 | 6 | GO:0061387 | |
| GeneOntologyBiologicalProcess | epithelium development | WHRN PRKD2 FLNB JMJD1C MST1 FASN SALL2 CLIC5 ALMS1 NFATC3 GLI2 LRP2 LRP5 ROBO1 NTN1 MST1L EMX1 EN1 PCDH8 EP300 NOTCH1 NOTCH4 HTT FOXJ1 FOXC2 | 6.67e-04 | 1469 | 175 | 25 | GO:0060429 |
| GeneOntologyBiologicalProcess | mesangial cell development | 7.04e-04 | 5 | 175 | 2 | GO:0072143 | |
| GeneOntologyBiologicalProcess | mesangial cell differentiation | 7.04e-04 | 5 | 175 | 2 | GO:0072007 | |
| GeneOntologyBiologicalProcess | regulation of mammary gland epithelial cell proliferation | 7.14e-04 | 21 | 175 | 3 | GO:0033599 | |
| GeneOntologyBiologicalProcess | cell projection assembly | DNAH1 CEP350 EVI5 CDKL5 PTPDC1 ABLIM1 ALMS1 TBC1D22A CSPG4 HRG NTN1 DNAH8 NOTCH1 HTT FOXJ1 | 7.64e-04 | 685 | 175 | 15 | GO:0030031 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX5 SIN3B TFEC KLF12 HNF1A TCF3 POU1F1 SIN3A BCL11A AHRR SALL2 HOXD8 NFATC3 GLI2 TLE1 FLCN RORC RERE EN1 EP300 NOTCH1 NOTCH4 FOXJ1 FOXC2 | 7.71e-04 | 1399 | 175 | 24 | GO:0045892 |
| GeneOntologyBiologicalProcess | cilium organization | DNAH1 CEP350 EVI5 CDKL5 PTPDC1 ABLIM1 ALMS1 TBC1D22A DNAH8 NOTCH1 HTT FOXJ1 | 7.83e-04 | 476 | 175 | 12 | GO:0044782 |
| GeneOntologyBiologicalProcess | growth | CLSTN3 XIRP1 PPAN SYT3 POU1F1 SIN3A BCL11A MST1 CDKL5 ALMS1 SEMA5B GLI2 HRG ROBO1 MACF1 NTN1 MST1L EMX1 EN1 EP300 NOTCH1 FOXC2 | 7.94e-04 | 1235 | 175 | 22 | GO:0040007 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CLSTN3 PCDHGA3 ITGA10 WNK1 TENM3 GLI2 LRP5 ROBO1 DLG4 NTN1 SIGLEC1 ZP4 PCDH8 PCDHGA8 EP300 NOTCH1 CDH15 CDH16 NOTCH4 FOXJ1 | 8.39e-04 | 1077 | 175 | 20 | GO:0098609 |
| GeneOntologyBiologicalProcess | head development | WHRN NCOA6 SCHIP1 SZT2 POU1F1 TACC2 SIN3A GLI2 SEC16A LRP2 ROBO1 RERE EMX1 EN1 EP300 NOTCH1 HTT FOXJ1 | 8.43e-04 | 919 | 175 | 18 | GO:0060322 |
| GeneOntologyBiologicalProcess | response to metal ion | SYT3 SLFN14 WNK1 ADCY8 TFR2 PPP5C NFATC3 DLG4 EP300 HTT SOD3 | 8.63e-04 | 415 | 175 | 11 | GO:0010038 |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 8.67e-04 | 233 | 175 | 8 | GO:0061351 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX5 SIN3B TFEC KLF12 HNF1A TCF3 POU1F1 SIN3A BCL11A AHRR SALL2 HOXD8 NFATC3 GLI2 TLE1 FLCN RORC RERE EN1 EP300 NOTCH1 NOTCH4 FOXJ1 FOXC2 | 8.85e-04 | 1413 | 175 | 24 | GO:1902679 |
| GeneOntologyBiologicalProcess | artery development | 9.65e-04 | 133 | 175 | 6 | GO:0060840 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | SYT3 POU1F1 SIN3A BCL11A CDKL5 ALMS1 MACF1 NTN1 EP300 NOTCH1 FOXC2 | 9.69e-04 | 421 | 175 | 11 | GO:0048638 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | PRKD2 SYT3 BCL11A WNK1 FAM171A1 CDKL5 NFATC3 PTPRZ1 AMOT SH3D19 HRG ROBO1 MACF1 DLG4 NTN1 EP300 NOTCH1 NOTCH4 FOXJ1 FOXC2 | 9.71e-04 | 1090 | 175 | 20 | GO:0022603 |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 9.94e-04 | 238 | 175 | 8 | GO:0048639 | |
| GeneOntologyCellularComponent | chromatin | SOX5 SIN3B TFEC KLF12 HNF1A TCF3 ERG CENPB ADNP2 POU1F1 SIN3A BCL11A KMT2E JMJD1C BSX AHRR PRDM10 HOXD8 NFATC3 ATXN7 FANCI RORC EMX1 EN1 EP300 FOXJ1 FOXC2 | 1.28e-04 | 1480 | 177 | 27 | GO:0000785 |
| GeneOntologyCellularComponent | MAML1-RBP-Jkappa- ICN1 complex | 2.13e-04 | 3 | 177 | 2 | GO:0002193 | |
| Domain | HDAC_interact | 8.83e-05 | 2 | 176 | 2 | SM00761 | |
| Domain | Sin3_C | 8.83e-05 | 2 | 176 | 2 | IPR031693 | |
| Domain | Sin3_corepress | 8.83e-05 | 2 | 176 | 2 | PF08295 | |
| Domain | Sin3a_C | 8.83e-05 | 2 | 176 | 2 | PF16879 | |
| Domain | HDAC_interact_dom | 8.83e-05 | 2 | 176 | 2 | IPR013194 | |
| Domain | PAH | 2.63e-04 | 3 | 176 | 2 | IPR003822 | |
| Domain | - | 2.63e-04 | 3 | 176 | 2 | 1.20.1160.11 | |
| Domain | PAH | 2.63e-04 | 3 | 176 | 2 | PS51477 | |
| Domain | PAH | 2.63e-04 | 3 | 176 | 2 | PF02671 | |
| Domain | Homeodomain-like | 3.21e-04 | 332 | 176 | 11 | IPR009057 | |
| Domain | - | 4.84e-04 | 39 | 176 | 4 | 2.120.10.30 | |
| Domain | Notch | 5.23e-04 | 4 | 176 | 2 | IPR008297 | |
| Domain | NODP | 5.23e-04 | 4 | 176 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 5.23e-04 | 4 | 176 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 5.23e-04 | 4 | 176 | 2 | IPR010660 | |
| Domain | NOD | 5.23e-04 | 4 | 176 | 2 | PF06816 | |
| Domain | NOD | 5.23e-04 | 4 | 176 | 2 | SM01338 | |
| Domain | NODP | 5.23e-04 | 4 | 176 | 2 | SM01339 | |
| Domain | CADHERIN_1 | 7.06e-04 | 113 | 176 | 6 | PS00232 | |
| Domain | Cadherin | 7.06e-04 | 113 | 176 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 7.40e-04 | 114 | 176 | 6 | PS50268 | |
| Domain | - | 7.40e-04 | 114 | 176 | 6 | 2.60.40.60 | |
| Domain | CA | 7.75e-04 | 115 | 176 | 6 | SM00112 | |
| Domain | Cadherin-like | 8.11e-04 | 116 | 176 | 6 | IPR015919 | |
| Domain | PAN_AP | 8.67e-04 | 5 | 176 | 2 | SM00473 | |
| Domain | LNR | 8.67e-04 | 5 | 176 | 2 | PS50258 | |
| Domain | Cadherin | 8.86e-04 | 118 | 176 | 6 | IPR002126 | |
| Domain | 6-blade_b-propeller_TolB-like | 9.13e-04 | 46 | 176 | 4 | IPR011042 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 7.98e-06 | 82 | 125 | 7 | MM15922 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.56e-05 | 20 | 125 | 4 | M27881 | |
| Pathway | PID_HES_HEY_PATHWAY | 6.38e-05 | 48 | 125 | 5 | M288 | |
| Pathway | WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM | 6.46e-05 | 113 | 125 | 7 | M48336 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 7.80e-05 | 10 | 125 | 3 | MM15535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.41e-04 | 12 | 125 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.41e-04 | 12 | 125 | 3 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.82e-04 | 13 | 125 | 3 | M47534 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.02e-04 | 61 | 125 | 5 | M39540 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 2.22e-04 | 34 | 125 | 4 | M39390 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.31e-04 | 14 | 125 | 3 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 3.50e-04 | 16 | 125 | 3 | M27121 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 3.81e-04 | 39 | 125 | 4 | MM14604 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 5.00e-04 | 74 | 125 | 5 | M616 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 5.04e-04 | 18 | 125 | 3 | MM14775 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 5.08e-04 | 42 | 125 | 4 | M17541 | |
| Pubmed | SOX5 SIN3B NCOA6 KLF12 HNF1A TCF3 PPAN ARID3A ERG DIS3L ACO2 COX6A1 MAML1 SIN3A BCL11A GPATCH8 UBN2 JMJD1C FHAD1 SALL2 ALMS1 NFATC3 ZNF592 ATXN7 GLI2 TLE1 SEC16A LRP2 SCAF11 RERE CPSF2 PUM1 EN1 EP300 | 1.23e-13 | 1429 | 182 | 34 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PRKD2 NCOA6 ARHGEF19 ATG10 ARID3A SZT2 COX6A1 MAML1 FRYL WNK1 BIRC6 IFNLR1 PCNX2 FASN ADAMTS7 ZNF592 FANCI CSPG4 SEC16A NLRC5 FLCN LRP5 PUM1 EP300 CRAMP1 NOTCH1 TOP3A HTT BAHCC1 | 9.07e-13 | 1105 | 182 | 29 | 35748872 |
| Pubmed | SOX5 SIN3B KLF12 HNF1A TCF3 ARID3A ERG CENPB TACC2 TUT1 BCL11A BIRC6 ABLIM1 AHRR SALL2 HOXD8 GLI2 MACF1 RORC TOP3A ZNF292 FOXC2 | 2.73e-11 | 709 | 182 | 22 | 22988430 | |
| Pubmed | PRKD2 ZSWIM8 DCAF6 CENPB DIS3L ADNP2 SIN3A BCL11A SALL2 ALMS1 ZNF592 ATXN7 CPEB4 SEC16A LRP2 MACF1 DLG4 SIGLEC1 RERE EP300 TENT2 CDH15 CDH16 SON ZNF574 BAHCC1 | 2.04e-10 | 1116 | 182 | 26 | 31753913 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB TCF3 DCAF6 STXBP5L FRMPD2 AFF3 FRYL UBN2 JMJD1C DNAH1 PCNX2 PTPDC1 ABLIM1 ARRB2 ATXN7 TBC1D22A ASMTL GLI2 NLRC5 LRP5 MACF1 NTN1 SCAF11 RERE EP300 CRAMP1 ADGRD1 CDH15 HTT | 1.06e-09 | 1489 | 182 | 29 | 28611215 |
| Pubmed | FLNB DCAF6 ELP1 KMT2E WNK1 BIRC6 JMJD1C ABLIM1 OPTN CLIC5 ALMS1 PPP5C ZNF592 AMOT MACF1 SON | 9.52e-09 | 497 | 182 | 16 | 23414517 | |
| Pubmed | ATXN2L SIN3B NCOA6 HBS1L SIN3A UBN2 JMJD1C SLC25A3 ABLIM1 FASN ALMS1 AMOT SH3D19 SEC16A EP300 HTT | 3.78e-08 | 549 | 182 | 16 | 38280479 | |
| Pubmed | FLNB SIN3B BIRC6 JMJD1C FASN ARRB2 SALL2 ALMS1 ZNF592 AMOT TLE1 SEC16A LRP2 RERE | 5.10e-08 | 418 | 182 | 14 | 34709266 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX5 TFEC KLF12 HNF1A TCF3 ERG ADNP2 POU1F1 BSX SALL2 HOXD8 NFATC3 GLI2 RORC RERE EMX1 EN1 CRAMP1 FOXJ1 FOXC2 | 7.30e-08 | 908 | 182 | 20 | 19274049 |
| Pubmed | SIN3B HBS1L DIS3L UBN2 WNK1 BIRC6 JMJD1C CEP350 VPS13D AHRR ALMS1 CPEB4 UBR3 MACF1 | 3.79e-07 | 493 | 182 | 14 | 15368895 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SOX5 NCOA6 ARID3A MAML1 BCL11A UBN2 ALMS1 TLE1 SEC16A RERE EP300 BAHCC1 | 3.80e-07 | 351 | 182 | 12 | 38297188 |
| Pubmed | WHRN XIRP1 PPAN KMT2E PCNX2 ALMS1 ATXN7 CRAMP1 NOTCH4 ZNF292 | 4.70e-07 | 233 | 182 | 10 | 37704626 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATXN2L ZSWIM8 MAML1 ELP1 TACC2 UBN2 WNK1 MST1 SALL2 ALMS1 NFATC3 SEC16A MACF1 TOP3A ZNF574 | 5.57e-07 | 588 | 182 | 15 | 38580884 |
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 12391150 | ||
| Pubmed | Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1. | 5.62e-07 | 4 | 182 | 3 | 22100894 | |
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 22203677 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SIN3B ARID3A CENPB MAML1 SIN3A CPOX JMJD1C FASN PRDM10 SALL2 ASMTL TLE1 CPSF2 PUM1 EP300 NOTCH1 FOXJ1 FOXC2 | 6.76e-07 | 857 | 182 | 18 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L NCOA6 NCKIPSD FRYL WNK1 CEP350 TTLL12 FAM171A1 ABLIM1 VPS13D OPTN ALMS1 NFATC3 AMOT SH3D19 SEC16A MACF1 PUM1 | 7.23e-07 | 861 | 182 | 18 | 36931259 |
| Pubmed | NCKIPSD ELP1 FRYL WNK1 BIRC6 ABLIM1 ALMS1 TBC1D22A AMOT CPEB4 SEC16A PUM1 NOTCH1 | 7.48e-07 | 446 | 182 | 13 | 24255178 | |
| Pubmed | ATXN2L ZSWIM8 CENPB ACO2 GPATCH8 WNK1 CEP350 ATXN7 LRP2 ADAM33 SCAF11 RERE PUM1 PCDH8 NOTCH1 | 8.45e-07 | 608 | 182 | 15 | 16713569 | |
| Pubmed | PRKD2 FLNB ZSWIM8 CLSTN3 DCAF6 ERG DIS3L CNTNAP1 ADNP2 CEP350 TTLL12 ABLIM1 PPP5C ZNF592 SH3D19 LRP2 ROBO1 MACF1 DLG4 TMEM131 EP300 ZNF292 | 1.15e-06 | 1285 | 182 | 22 | 35914814 | |
| Pubmed | 1.40e-06 | 5 | 182 | 3 | 18611861 | ||
| Pubmed | 1.40e-06 | 5 | 182 | 3 | 21124806 | ||
| Pubmed | 1.40e-06 | 5 | 182 | 3 | 11101851 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SOX5 HBS1L C3orf62 NCKIPSD ADNP2 MAML1 JMJD1C TLE1 SEC16A EP300 ZNF292 BAHCC1 | 1.42e-06 | 398 | 182 | 12 | 35016035 |
| Pubmed | 1.49e-06 | 152 | 182 | 8 | 38360978 | ||
| Pubmed | ATXN2L MAML1 GPATCH8 WNK1 BIRC6 JMJD1C CEP350 ABLIM1 ALMS1 TBC1D22A TLE1 SEC16A ROBO1 TMEM131 CPSF2 PUM1 | 1.77e-06 | 733 | 182 | 16 | 34672954 | |
| Pubmed | WHRN CLSTN3 AVL9 BCL11A GPATCH8 ABLIM1 TENM3 SEC16A MACF1 RERE PUM1 SON | 1.79e-06 | 407 | 182 | 12 | 12693553 | |
| Pubmed | ATXN2L SIN3B TFEC KLF12 SZT2 ACO2 CPOX GPATCH8 WNK1 BIRC6 MST1 FASN PRDM10 TLE1 SEC16A FLCN RERE EP300 CRAMP1 HTT ZNF574 ZNF292 | 1.94e-06 | 1327 | 182 | 22 | 32694731 | |
| Pubmed | 2.36e-06 | 217 | 182 | 9 | 34048709 | ||
| Pubmed | 2.79e-06 | 6 | 182 | 3 | 19838210 | ||
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 2.79e-06 | 6 | 182 | 3 | 15019995 | |
| Pubmed | 2.79e-06 | 6 | 182 | 3 | 32929029 | ||
| Pubmed | SOX5 PRKD2 FLNB NCOA6 SEC24D OPTN ARRB2 TENM3 ZNF592 CSPG4 LRP5 MACF1 PUM1 SON | 3.17e-06 | 591 | 182 | 14 | 15231748 | |
| Pubmed | 3.17e-06 | 225 | 182 | 9 | 12168954 | ||
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 11585921 | ||
| Pubmed | The mouse mahogany locus encodes a transmembrane form of human attractin. | 4.86e-06 | 7 | 182 | 3 | 10086356 | |
| Pubmed | 5.11e-06 | 83 | 182 | 6 | 28794006 | ||
| Pubmed | EPHX1 ATXN2L FLNB HBS1L JMJD1C SLC25A3 FAM171A1 ABLIM1 FASN FANCI SH3D19 SEC16A ROBO1 MACF1 NOTCH1 | 5.40e-06 | 708 | 182 | 15 | 39231216 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | KLF12 TCF3 TACC2 FRYL JMJD1C VPS13D TENM3 GLI2 SH3D19 NTN1 SCAF11 RERE PUM1 | 5.59e-06 | 536 | 182 | 13 | 15840001 |
| Pubmed | KLF12 TCF3 TACC2 FRYL JMJD1C VPS13D TENM3 GLI2 SH3D19 NTN1 SCAF11 RERE PUM1 | 5.82e-06 | 538 | 182 | 13 | 10512203 | |
| Pubmed | SOX5 HNF1A SOST POU1F1 ARRB2 HOXD8 GLI2 LRP5 EN1 NOTCH1 FOXC2 | 6.24e-06 | 383 | 182 | 11 | 19453261 | |
| Pubmed | 6.72e-06 | 87 | 182 | 6 | 12465718 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | SOX5 ATXN2L FLNB ZSWIM8 NCKIPSD TACC2 FRYL SIN3A BCL11A SLC25A3 CDKL5 DLG4 NOTCH1 | 8.92e-06 | 560 | 182 | 13 | 21653829 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | WHRN HBS1L TRIM25 COX6A1 AFF3 ELP1 FRYL JMJD1C IFNLR1 MST1 EVI5 OPTN PPP5C IFITM3 TBC1D22A FANCI DLG4 SCAF11 MST1L ADGRD1 | 8.98e-06 | 1242 | 182 | 20 | 30973865 |
| Pubmed | ATXN2L FLNB ZSWIM8 ELP1 FRYL BIRC6 TTLL12 FASN FANCI SEC16A MACF1 SCAF11 PUM1 SON | 9.83e-06 | 653 | 182 | 14 | 22586326 | |
| Pubmed | 1.12e-05 | 263 | 182 | 9 | 34702444 | ||
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 1.14e-05 | 56 | 182 | 5 | 9455484 | |
| Pubmed | 1.16e-05 | 9 | 182 | 3 | 12370315 | ||
| Pubmed | FLNB MARCHF6 GPATCH8 BIRC6 GLI2 FLCN MACF1 TMEM131 PUM1 ZNF292 | 1.19e-05 | 335 | 182 | 10 | 15741177 | |
| Pubmed | ATXN2L FLNB PPAN TACC2 WNK1 FASN FANCI SSH3 SEC16A TMEM131 SON ZNF574 | 1.52e-05 | 503 | 182 | 12 | 16964243 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L NCOA6 PPAN ERG SIN3A GPATCH8 ABLIM1 FASN ZNF592 ATXN7 SEC16A SCAF11 RERE CPSF2 SON | 1.55e-05 | 774 | 182 | 15 | 15302935 |
| Pubmed | 1.55e-05 | 274 | 182 | 9 | 34244482 | ||
| Pubmed | 1.55e-05 | 209 | 182 | 8 | 36779422 | ||
| Pubmed | 1.61e-05 | 60 | 182 | 5 | 34761192 | ||
| Pubmed | 1.63e-05 | 152 | 182 | 7 | 34299191 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | HNF1A TCF3 TRIM25 ERG CENPB MAML1 SIN3A NFATC3 ZNF592 TLE1 RORC RERE EMX1 EP300 ZNF292 FOXJ1 | 1.67e-05 | 877 | 182 | 16 | 20211142 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 KLF12 TRIM25 SIN3A TEX14 KMT2E WNK1 ARRB2 GLI2 NOTCH1 SON | 1.83e-05 | 430 | 182 | 11 | 35044719 |
| Pubmed | 2.04e-05 | 31 | 182 | 4 | 24014668 | ||
| Pubmed | 2.26e-05 | 11 | 182 | 3 | 15546612 | ||
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 2.26e-05 | 11 | 182 | 3 | 15499562 | |
| Pubmed | Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation. | 2.72e-05 | 2 | 182 | 2 | 24305720 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 12496471 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 30009847 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 11112321 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 27609031 | ||
| Pubmed | Regulation of LEF-1/TCF transcription factors by Wnt and other signals. | 2.72e-05 | 2 | 182 | 2 | 10209158 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 20972443 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 10728827 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 16961763 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 32017081 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 23901037 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 25411494 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 34781999 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 11319238 | ||
| Pubmed | Bidirectional control of postsynaptic density-95 (PSD-95) clustering by Huntingtin. | 2.72e-05 | 2 | 182 | 2 | 24347167 | |
| Pubmed | Human Placental LRP5 and Sclerostin are Increased in Gestational Diabetes Mellitus Pregnancies. | 2.72e-05 | 2 | 182 | 2 | 36947076 | |
| Pubmed | Mst1 regulates post-infarction cardiac injury through the JNK-Drp1-mitochondrial fission pathway. | 2.72e-05 | 2 | 182 | 2 | 29760744 | |
| Pubmed | Critical role of endothelial Notch1 signaling in postnatal angiogenesis. | 2.72e-05 | 2 | 182 | 2 | 17158336 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 26934656 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 31206688 | ||
| Pubmed | Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. | 2.72e-05 | 2 | 182 | 2 | 22084425 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 19726651 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 24606091 | ||
| Pubmed | NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury. | 2.72e-05 | 2 | 182 | 2 | 19604403 | |
| Pubmed | Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma. | 2.72e-05 | 2 | 182 | 2 | 23742774 | |
| Pubmed | Site-specific abnormalities in the visual system of a mouse model of CDKL5 deficiency disorder. | 2.72e-05 | 2 | 182 | 2 | 31108505 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 16990791 | ||
| Pubmed | Differential Complex Formation via Paralogs in the Human Sin3 Protein Interaction Network. | 2.72e-05 | 2 | 182 | 2 | 32467258 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 29212017 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 8393443 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 23389453 | ||
| Pubmed | Thymosin beta4 induces angiogenesis through Notch signaling in endothelial cells. | 2.72e-05 | 2 | 182 | 2 | 23749167 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 24980820 | ||
| Pubmed | Notch-1 and notch-4 receptors as prognostic markers in breast cancer. | 2.72e-05 | 2 | 182 | 2 | 20444726 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 25762686 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 25640331 | ||
| Pubmed | Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice. | 2.72e-05 | 2 | 182 | 2 | 39253972 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 21855668 | ||
| Pubmed | Transcription of RORγt in developing Th17 cells is regulated by E-proteins. | 2.72e-05 | 2 | 182 | 2 | 24064669 | |
| Interaction | MAML2 interactions | 2.89e-07 | 17 | 178 | 5 | int:MAML2 | |
| Interaction | EGR2 interactions | SOX5 NCOA6 ARID3A MAML1 BCL11A UBN2 TLE1 SEC16A RERE EP300 BAHCC1 | 3.64e-07 | 171 | 178 | 11 | int:EGR2 |
| Interaction | SOX7 interactions | 6.46e-07 | 82 | 178 | 8 | int:SOX7 | |
| Interaction | SMG7 interactions | ZSWIM8 NCOA6 TRIM25 ARID3A MAML1 GPATCH8 JMJD1C FASN SALL2 AMOT TLE1 CPEB4 SEC16A PUM1 | 9.87e-07 | 319 | 178 | 14 | int:SMG7 |
| Interaction | BRPF3 interactions | 2.27e-06 | 166 | 178 | 10 | int:BRPF3 | |
| Interaction | CEP85 interactions | 2.67e-06 | 169 | 178 | 10 | int:CEP85 | |
| Interaction | TOP3B interactions | PRKD2 NCOA6 ARHGEF19 ATG10 TRIM25 ARID3A SZT2 COX6A1 MAML1 FRYL WNK1 BIRC6 IFNLR1 PCNX2 FASN ADAMTS7 ZNF592 FANCI CSPG4 CPEB4 SEC16A NLRC5 FLCN LRP5 PUM1 EP300 CRAMP1 NOTCH1 TOP3A HTT BAHCC1 | 4.99e-06 | 1470 | 178 | 31 | int:TOP3B |
| Interaction | WWTR1 interactions | ATXN2L SIN3B NCOA6 HBS1L TRIM25 SIN3A JMJD1C ABLIM1 ALMS1 AMOT SH3D19 SEC16A EP300 NOTCH1 HTT | 5.42e-06 | 422 | 178 | 15 | int:WWTR1 |
| Interaction | NFIA interactions | 6.90e-06 | 188 | 178 | 10 | int:NFIA | |
| Interaction | YWHAB interactions | ATXN2L HNF1A TRIM25 NCKIPSD FRYL WNK1 CEP350 FAM171A1 PTPDC1 ABLIM1 VPS13D OPTN ARRB2 PPP5C NFATC3 TBC1D22A AMOT SH3D19 MACF1 DLG4 PUM1 PDE7B HTT SON | 1.04e-05 | 1014 | 178 | 24 | int:YWHAB |
| Interaction | DLL4 interactions | 1.33e-05 | 6 | 178 | 3 | int:DLL4 | |
| Interaction | YWHAG interactions | ATXN2L NCOA6 HNF1A NCKIPSD FRYL WNK1 CEP350 TTLL12 SLC25A3 FAM171A1 PTPDC1 ABLIM1 VPS13D OPTN ARRB2 ALMS1 NFATC3 AMOT SH3D19 SEC16A MACF1 DLG4 SCAF11 PUM1 PDE7B HTT SON | 1.41e-05 | 1248 | 178 | 27 | int:YWHAG |
| Interaction | YWHAQ interactions | PRKD2 ATXN2L NCOA6 TCF3 TRIM25 NCKIPSD FRYL TUT1 WNK1 PANK1 CEP350 FAM171A1 PTPDC1 ABLIM1 FASN VPS13D OPTN ARRB2 PPP5C NFATC3 SH3D19 MACF1 PUM1 PDE7B HTT | 1.76e-05 | 1118 | 178 | 25 | int:YWHAQ |
| Interaction | KDM1A interactions | FLNB SIN3B TCF3 TRIM25 SIN3A BIRC6 JMJD1C CEP350 FASN ARRB2 SALL2 ALMS1 ZNF592 AMOT SH3D19 SEC16A LRP2 RERE CPSF2 EP300 NOTCH1 HTT | 3.03e-05 | 941 | 178 | 22 | int:KDM1A |
| Interaction | RCOR1 interactions | SOX5 SIN3B KLF12 TCF3 TRIM25 SIN3A BIRC6 JMJD1C FASN ARRB2 SALL2 ALMS1 ZNF592 AMOT SEC16A | 3.45e-05 | 494 | 178 | 15 | int:RCOR1 |
| Interaction | ING1 interactions | 3.62e-05 | 103 | 178 | 7 | int:ING1 | |
| Interaction | ZYX interactions | ARHGEF19 TRIM25 WNK1 CEP350 TTLL12 ABLIM1 ALMS1 AMOT SH3D19 SEC16A MACF1 EP300 | 3.78e-05 | 329 | 178 | 12 | int:ZYX |
| Interaction | CNOT9 interactions | DIS3L BIRC6 JMJD1C CEP350 ALMS1 GLI2 CPEB4 SEC16A TMEM131 PUM1 | 4.09e-05 | 231 | 178 | 10 | int:CNOT9 |
| Interaction | MOB1A interactions | 4.21e-05 | 72 | 178 | 6 | int:MOB1A | |
| Interaction | UTY interactions | 4.57e-05 | 23 | 178 | 4 | int:UTY | |
| Interaction | ATXN1L interactions | 5.73e-05 | 150 | 178 | 8 | int:ATXN1L | |
| Interaction | SYT2 interactions | 5.73e-05 | 150 | 178 | 8 | int:SYT2 | |
| Interaction | KCNAB1 interactions | 6.44e-05 | 25 | 178 | 4 | int:KCNAB1 | |
| Interaction | LAMTOR5 interactions | 6.59e-05 | 153 | 178 | 8 | int:LAMTOR5 | |
| Interaction | DKK2 interactions | 7.07e-05 | 49 | 178 | 5 | int:DKK2 | |
| Interaction | EGLN3 interactions | ZSWIM8 HBS1L TCF3 TRIM25 MAML1 ELP1 GPATCH8 BIRC6 JMJD1C CEP350 TTLL12 SLC25A3 FAM171A1 FASN PPP5C NFATC3 AMOT FANCI GLI2 CPEB4 SEC16A FLCN ROBO1 TMEM131 PUM1 TOP3A | 7.37e-05 | 1296 | 178 | 26 | int:EGLN3 |
| Interaction | BCOR interactions | SOX5 KLF12 HNF1A TCF3 TRIM25 ERG JMJD1C AMOT SEC16A SCAF11 EN1 | 8.09e-05 | 302 | 178 | 11 | int:BCOR |
| Interaction | FEV interactions | 8.31e-05 | 203 | 178 | 9 | int:FEV | |
| Interaction | SP7 interactions | SOX5 SIN3B NCOA6 ARID3A MAML1 SIN3A GPATCH8 TLE1 RERE CPSF2 EP300 | 8.58e-05 | 304 | 178 | 11 | int:SP7 |
| Interaction | CRX interactions | 9.05e-05 | 254 | 178 | 10 | int:CRX | |
| Interaction | KDM2B interactions | 9.42e-05 | 161 | 178 | 8 | int:KDM2B | |
| Interaction | RXFP3 interactions | 1.06e-04 | 11 | 178 | 3 | int:RXFP3 | |
| Interaction | YWHAH interactions | PRKD2 ATXN2L NCOA6 NCKIPSD FRYL WNK1 CEP350 FAM171A1 PTPDC1 ABLIM1 VPS13D OPTN ARRB2 ALMS1 TFB1M NFATC3 AMOT SH3D19 SEC16A FLCN MACF1 PUM1 HTT | 1.12e-04 | 1102 | 178 | 23 | int:YWHAH |
| Interaction | TLE1 interactions | 1.20e-04 | 213 | 178 | 9 | int:TLE1 | |
| Interaction | GSC interactions | 1.22e-04 | 87 | 178 | 6 | int:GSC | |
| Interaction | TLE3 interactions | TCF3 ERG MAML1 GPATCH8 UBN2 GLI2 TLE1 RERE EN1 EP300 NOTCH1 SON | 1.35e-04 | 376 | 178 | 12 | int:TLE3 |
| Interaction | GLDC interactions | ATXN2L FLNB SOST TRIM25 ABLIM1 FASN PPP5C AMOT SEC16A CPSF2 PUM1 | 1.39e-04 | 321 | 178 | 11 | int:GLDC |
| Interaction | SFN interactions | ATXN2L NCOA6 TCF3 TRIM25 FRYL TEX14 WNK1 CEP350 FAM171A1 ABLIM1 ALMS1 NFATC3 AMOT SH3D19 MACF1 PUM1 HTT | 1.42e-04 | 692 | 178 | 17 | int:SFN |
| Interaction | VPS4A interactions | 1.56e-04 | 91 | 178 | 6 | int:VPS4A | |
| Interaction | GATAD1 interactions | 1.66e-04 | 131 | 178 | 7 | int:GATAD1 | |
| Interaction | CNOT2 interactions | 1.89e-04 | 178 | 178 | 8 | int:CNOT2 | |
| Interaction | ALG13 interactions | 2.28e-04 | 183 | 178 | 8 | int:ALG13 | |
| Interaction | ATF7IP interactions | 2.28e-04 | 138 | 178 | 7 | int:ATF7IP | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | TRIM25 AFF3 MAML1 SLC15A3 WNK1 BIRC6 SLFN13 TLE1 FLCN NOTCH1 | 1.32e-06 | 200 | 180 | 10 | M291 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PRKD2 ATXN2L KLF12 CLSTN3 MARCHF6 ELP1 FRYL SIN3A GPATCH8 KMT2E WNK1 BIRC6 JMJD1C DEGS1 CEP350 PCNX2 ARRB2 CLIC5 NFATC3 ATXN7 NLRC5 MACF1 SCAF11 EP300 NOTCH1 SON ZNF292 | 3.89e-06 | 1492 | 180 | 27 | M40023 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.53e-06 | 180 | 180 | 9 | M8239 | |
| Coexpression | GSE3982_MAC_VS_BCELL_DN | 9.41e-06 | 197 | 180 | 9 | M5495 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_20P13_AMPLICON | 1.74e-05 | 8 | 180 | 3 | M6821 | |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | 2.90e-05 | 227 | 180 | 9 | M18441 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | BIRC6 CEP350 VPS13D PRDM10 CLIC5 ALMS1 NFATC3 SCAF11 TMEM131 EP300 | 4.50e-09 | 186 | 179 | 10 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | XIRP1 SOST ITGA10 SEMA5B PTPRZ1 RBPMS2 CSPG4 ADAM33 SOD3 FOXC2 | 4.99e-09 | 188 | 179 | 10 | 6ec22b79b19d57ea187f312907819dc2d01f3efe |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.11e-09 | 192 | 179 | 10 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.42e-09 | 193 | 179 | 10 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | FRYL KMT2E BIRC6 JMJD1C CEP350 MACF1 SCAF11 SIGLEC1 SON ZNF292 | 9.03e-09 | 200 | 179 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.53e-08 | 166 | 179 | 9 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.45e-08 | 191 | 179 | 9 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.45e-08 | 191 | 179 | 9 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.45e-08 | 191 | 179 | 9 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.45e-08 | 191 | 179 | 9 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 8.45e-08 | 191 | 179 | 9 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.25e-07 | 200 | 179 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.61e-07 | 182 | 179 | 8 | 9c120ddd109103ef6fac9c32b84d16a7624d0580 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.71e-07 | 188 | 179 | 8 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.71e-07 | 188 | 179 | 8 | 18d16e3f095a109b6a690f46fe7fcd5674c3636b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-06 | 189 | 179 | 8 | 2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 189 | 179 | 8 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 189 | 179 | 8 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-06 | 190 | 179 | 8 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 192 | 179 | 8 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 192 | 179 | 8 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | P15-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.14e-06 | 192 | 179 | 8 | a476895b7b252c388d6346eacbc72f0115b1443e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-06 | 193 | 179 | 8 | 323d1f3f4fbeb93ba857fc135d8aa0b897f98ac5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-06 | 193 | 179 | 8 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-06 | 193 | 179 | 8 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-06 | 194 | 179 | 8 | aaecde88bd54134a938e76cdf059c1c2653e4e77 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.23e-06 | 194 | 179 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-06 | 194 | 179 | 8 | 2b5eee7c3e52b63cce94205d18133c7704329c02 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-06 | 195 | 179 | 8 | 43d372373367b71243c6ea958aedccde4478618f | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.43e-06 | 198 | 179 | 8 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.80e-06 | 174 | 179 | 7 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.06e-06 | 175 | 179 | 7 | 1b3510e9078eec7cfc5805043e435e9e5e0f0877 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.06e-06 | 175 | 179 | 7 | eaec7fda07a9537d067ca13b607a8ab201caa7c4 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.89e-06 | 178 | 179 | 7 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.89e-06 | 178 | 179 | 7 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 9.45e-06 | 183 | 179 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-05 | 187 | 179 | 7 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 187 | 179 | 7 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 187 | 179 | 7 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-05 | 187 | 179 | 7 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 188 | 179 | 7 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 188 | 179 | 7 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.17e-05 | 189 | 179 | 7 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-05 | 190 | 179 | 7 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-05 | 191 | 179 | 7 | 6a8b0987e75456a257954288206da0032605ff2a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 191 | 179 | 7 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.25e-05 | 191 | 179 | 7 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 192 | 179 | 7 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 192 | 179 | 7 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.34e-05 | 193 | 179 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.34e-05 | 193 | 179 | 7 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.34e-05 | 193 | 179 | 7 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-05 | 193 | 179 | 7 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.34e-05 | 193 | 179 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-05 | 193 | 179 | 7 | 7fc3ab7261c88c1df71744bf5b17e8e46c4300e0 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.34e-05 | 193 | 179 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 193 | 179 | 7 | dd9874898587fe9fd9cf2aebc2e0579dcf06944e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 194 | 179 | 7 | 6a4e7f1bf67bad94cd8c472e7c66798b0c25ba01 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 194 | 179 | 7 | f08a7618a9ccf12e4a7620235ae662a8abc521af | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 195 | 179 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 195 | 179 | 7 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 195 | 179 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.43e-05 | 195 | 179 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 179 | 7 | c51b1bee79e77aa2ac444a4883ef533c0095eaad | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.52e-05 | 197 | 179 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.58e-05 | 198 | 179 | 7 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_intermediate|Influenza_Severe / Disease, condition lineage and cell class | 1.58e-05 | 198 | 179 | 7 | ab622fee61714471af3a7be0af356e8a484dcaff | |
| ToppCell | AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.58e-05 | 198 | 179 | 7 | 893036558a9ad86b57f9e735df35812e9d18739e | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.58e-05 | 198 | 179 | 7 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.58e-05 | 198 | 179 | 7 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.63e-05 | 199 | 179 | 7 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_CD56bright|COVID-19_Mild / Disease, condition lineage and cell class | 1.68e-05 | 200 | 179 | 7 | bb21e26a8b7cbceddb1ab5163a223a186d914da4 | |
| ToppCell | severe-NK_CD56bright|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.68e-05 | 200 | 179 | 7 | 82818ab1796fdd0b8be02b341818897595eed841 | |
| ToppCell | Control-NK|World / Disease group and Cell class | 2.48e-05 | 143 | 179 | 6 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_C|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.37e-05 | 151 | 179 | 6 | 3f2abaa42876ce7a71d934ff16abe0cab0991a05 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.66e-05 | 160 | 179 | 6 | 8aaf6ac4f33ea291387fdbf9ff1a91d559391774 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 160 | 179 | 6 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-05 | 162 | 179 | 6 | 36ddebe3bb172c992739353b7b049b2dde98b559 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 5.71e-05 | 166 | 179 | 6 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 168 | 179 | 6 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 168 | 179 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 168 | 179 | 6 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.11e-05 | 168 | 179 | 6 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.11e-05 | 168 | 179 | 6 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 168 | 179 | 6 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 169 | 179 | 6 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 169 | 179 | 6 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.52e-05 | 170 | 179 | 6 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 6.52e-05 | 170 | 179 | 6 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.52e-05 | 170 | 179 | 6 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 7.18e-05 | 173 | 179 | 6 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | Influenza_Severe-B_intermediate|Influenza_Severe / Disease group and Cell class | 7.41e-05 | 174 | 179 | 6 | 4276bdaac53aebd3084323a90ecde572d3177446 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.65e-05 | 175 | 179 | 6 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.65e-05 | 175 | 179 | 6 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-05 | 175 | 179 | 6 | 6759d200a133034756de9cdf2d5daceca927aac9 | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 7.90e-05 | 176 | 179 | 6 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | normal_Lung-Endothelial_cells-EPCs|normal_Lung / Location, Cell class and cell subclass | 7.90e-05 | 176 | 179 | 6 | 71d1bd425772d89d8c550b909e0ec0e36ff22a7e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.15e-05 | 177 | 179 | 6 | 4553ee8cd9c24db6511b09fe49ed11a89e7cde9e | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.40e-05 | 178 | 179 | 6 | e2363810d77b6b245394a666eb51bacd345c43f7 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 8.67e-05 | 179 | 179 | 6 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| Computational | Neighborhood of ATRX | MARCHF6 NCKIPSD FRYL GPATCH8 CEP350 PPP5C ZNF592 TBC1D22A RERE ZNF292 | 6.31e-05 | 215 | 109 | 10 | MORF_ATRX |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | WHRN ATXN2L ERG WNK1 ZNF592 TBC1D22A SSH3 NTN1 RORC RERE EN1 | 4.86e-07 | 195 | 181 | 11 | 4124_UP |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; PC3; HT_HG-U133A | WHRN ATXN2L KLF12 STXBP5L WNK1 OPTN TBC1D22A SSH3 FLCN TOP3A BAHCC1 | 5.37e-07 | 197 | 181 | 11 | 5045_UP |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | ATG10 MARCHF6 ADNP2 BCL11A WNK1 CEP350 ABLIM1 ATXN7 LRP2 ZNF292 | 3.19e-06 | 191 | 181 | 10 | 4279_DN |
| Drug | Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A | KLF12 ATG10 SZT2 MARCHF6 TUT1 TRMT2B FAM171A1 SEC24D ALMS1 TLE1 | 3.34e-06 | 192 | 181 | 10 | 2219_UP |
| Drug | Ricinine [524-40-3]; Up 200; 24.4uM; HL60; HT_HG-U133A | ZSWIM8 KLF12 SPAG4 ERG POU1F1 ZNF280B SLC22A18AS FASN NTN1 EN1 | 4.39e-06 | 198 | 181 | 10 | 2505_UP |
| Drug | Azathymine, 6 [932-53-6]; Up 200; 31.4uM; PC3; HT_HG-U133A | 4.59e-06 | 199 | 181 | 10 | 3987_UP | |
| Drug | benzo(ghi)perylene | 1.36e-05 | 19 | 181 | 4 | CID000009117 | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A | ATXN2L ZSWIM8 HBS1L MARCHF6 SEC24D CLIC5 ADAMTS7 NFATC3 RERE | 1.38e-05 | 179 | 181 | 9 | 3630_UP |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; HL60; HG-U133A | 2.32e-05 | 191 | 181 | 9 | 1417_UP | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 2.41e-05 | 192 | 181 | 9 | 1517_DN | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 2.62e-05 | 194 | 181 | 9 | 5457_DN | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.73e-05 | 195 | 181 | 9 | 4235_DN | |
| Drug | 17-AAG; Up 200; 1uM; ssMCF7; HG-U133A | GPATCH8 WNK1 SLC22A18AS ABLIM1 ARRB2 CLIC5 IFITM3 SIGLEC1 EN1 | 2.73e-05 | 195 | 181 | 9 | 521_UP |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A | 2.84e-05 | 196 | 181 | 9 | 1323_UP | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 7495_UP | |
| Drug | Ivermectin [70288-86-7]; Up 200; 4.6uM; HL60; HG-U133A | 2.96e-05 | 197 | 181 | 9 | 1367_UP | |
| Drug | Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; MCF7; HT_HG-U133A | ERG STXBP5L SLC22A18AS VPS13D CLIC5 NFATC3 TBC1D22A RERE BAHCC1 | 3.07e-05 | 198 | 181 | 9 | 1518_UP |
| Drug | Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.07e-05 | 198 | 181 | 9 | 4062_DN | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 3.33e-05 | 200 | 181 | 9 | 3322_UP | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; HL60; HG-U133A | 3.33e-05 | 200 | 181 | 9 | 2044_UP | |
| Drug | coprogen | 4.01e-05 | 9 | 181 | 3 | CID006323272 | |
| Disease | Malignant neoplasm of breast | FLNB NCOA6 XIRP1 ATG10 SYT3 ACO2 ELP1 TACC2 BCL11A WNK1 MST1 FASN SEMA5B NLRC5 HRG ROBO1 MACF1 ADAM33 KLHDC7A PCDH8 EP300 NOTCH1 NOTCH4 | 1.35e-07 | 1074 | 177 | 23 | C0006142 |
| Disease | obsolete_red blood cell distribution width | MARS2 HNF1A HBS1L AQP10 AVL9 C3orf62 BCL11A SLFN14 WNK1 BIRC6 TFR2 AHRR ATXN7 FANCI CPEB4 UGT2B10 LRP5 PPP1R36 PDE7B EP300 NOTCH1 CDH15 | 2.04e-05 | 1347 | 177 | 22 | EFO_0005192 |
| Disease | eosinophil count | PRKD2 KLF12 HBS1L SCHIP1 SOST ERG ACO2 NCKIPSD CPOX WNK1 TFR2 CLIC5 PPP5C IFITM3 CPEB4 SEC16A NLRC5 TMEM131 RERE NOTCH1 NOTCH4 ZNF292 BAHCC1 | 3.09e-05 | 1488 | 177 | 23 | EFO_0004842 |
| Disease | Adenoid Cystic Carcinoma | 3.20e-05 | 100 | 177 | 6 | C0010606 | |
| Disease | Birt-Hogg-Dube syndrome (is_implicated_in) | 3.58e-05 | 2 | 177 | 2 | DOID:0050676 (is_implicated_in) | |
| Disease | Birt-Hogg-Dube syndrome | 3.58e-05 | 2 | 177 | 2 | cv:C0346010 | |
| Disease | Multiple fibrofolliculomas | 3.58e-05 | 2 | 177 | 2 | cv:C5779556 | |
| Disease | Seizures | 5.46e-05 | 218 | 177 | 8 | C0036572 | |
| Disease | Intellectual Disability | AFF3 SIN3A BCL11A KMT2E FASN LRP2 MACF1 DLG4 PUM1 HTT ZNF292 | 8.76e-05 | 447 | 177 | 11 | C3714756 |
| Disease | total blood protein measurement | SOX5 ZSWIM8 CLSTN3 TRIM25 AFF3 DNAH1 NFATC3 SEC16A MACF1 TMEM131 SIGLEC1 | 9.12e-05 | 449 | 177 | 11 | EFO_0004536 |
| Disease | serum iron measurement | 1.73e-04 | 86 | 177 | 5 | EFO_0006332 | |
| Disease | hemoglobin measurement, fetal hemoglobin measurement | 2.13e-04 | 4 | 177 | 2 | EFO_0004509, EFO_0004576 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.15e-04 | 49 | 177 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.50e-04 | 145 | 177 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | SOX5 ATXN2L SZT2 COX6A1 AFF3 TACC2 FRYL JMJD1C ABLIM1 CPEB4 ROBO1 MACF1 NTN1 RERE HTT BAHCC1 FOXJ1 | 2.56e-04 | 1069 | 177 | 17 | EFO_0004346 |
| Disease | Childhood Acute Lymphoblastic Leukemia | 2.71e-04 | 52 | 177 | 4 | C0023452 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.76e-04 | 276 | 177 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | obesity (implicated_via_orthology) | 3.33e-04 | 215 | 177 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | urate measurement | PRKD2 NCOA6 HNF1A SIN3A TEX14 BIRC6 JMJD1C DNAH1 SLC22A18AS PTPDC1 NFATC3 CSPG4 CPEB4 LRP2 RORC | 3.45e-04 | 895 | 177 | 15 | EFO_0004531 |
| Disease | creatinine measurement | SOX5 PRKD2 HNF1A C3orf62 SIN3A BIRC6 CDKL5 ALMS1 ADAMTS7 ZNF592 IFITM3 ATXN7 CSPG4 LRP2 KLHDC7A SOD3 | 3.45e-04 | 995 | 177 | 16 | EFO_0004518 |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 3.83e-04 | 157 | 177 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | inflammatory bowel disease | 4.05e-04 | 449 | 177 | 10 | EFO_0003767 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 4.30e-04 | 295 | 177 | 8 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | Malignant neoplasm of skin | 4.40e-04 | 59 | 177 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 4.40e-04 | 59 | 177 | 4 | C0037286 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 5.00e-04 | 61 | 177 | 4 | C1961102 | |
| Disease | Pituitary Hormone Deficiency, Combined, 1 | 5.28e-04 | 6 | 177 | 2 | C2751608 | |
| Disease | portal hypertension (is_marker_for) | 5.28e-04 | 6 | 177 | 2 | DOID:10762 (is_marker_for) | |
| Disease | hemoglobin E disease | 5.28e-04 | 6 | 177 | 2 | MONDO_0016243 | |
| Disease | myeloid white cell count | FLNB KLF12 HNF1A HBS1L ERG ITGA10 KMT2E JMJD1C TTLL12 SH3D19 NLRC5 ADAM33 RERE HTT ZNF292 | 5.55e-04 | 937 | 177 | 15 | EFO_0007988 |
| Disease | platelet component distribution width | TFEC HBS1L SIN3A SLFN14 VWA7 WNK1 JMJD1C CLIC5 RBPMS2 MACF1 ADAM33 SIGLEC1 GP9 | 6.70e-04 | 755 | 177 | 13 | EFO_0007984 |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 7.14e-04 | 67 | 177 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | lymphocyte measurement | 7.15e-04 | 117 | 177 | 5 | EFO_0803546 | |
| Disease | RENAL CELL CARCINOMA, NONPAPILLARY | 7.37e-04 | 7 | 177 | 2 | 144700 | |
| Disease | Nonpapillary renal cell carcinoma | 7.37e-04 | 7 | 177 | 2 | cv:CN074294 | |
| Disease | panhypopituitarism (is_implicated_in) | 7.37e-04 | 7 | 177 | 2 | DOID:9410 (is_implicated_in) | |
| Disease | behenoyl dihydrosphingomyelin (d18:0/22:0) measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0800427 | |
| Disease | hemoglobin A2 measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0005845 | |
| Disease | 40S ribosomal protein S4, X isoform measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0801334 | |
| Disease | central serous retinopathy | 9.78e-04 | 8 | 177 | 2 | EFO_0009784 | |
| Disease | C-reactive protein measurement | SOX5 ATXN2L ZSWIM8 NCOA6 HNF1A AQP10 COX6A1 HID1 ADCY8 IFNLR1 PPP5C SEC16A MACF1 DLG4 RORC SCAF11 RERE | 9.90e-04 | 1206 | 177 | 17 | EFO_0004458 |
| Disease | sexual dimorphism measurement | SOX5 ATXN2L NCOA6 HNF1A SOST SPAG4 C3orf62 COX6A1 FRYL JMJD1C ADCY8 ZNF592 GLI2 SEC16A NLRC5 MACF1 | 1.07e-03 | 1106 | 177 | 16 | EFO_0021796 |
| Disease | Colorectal Carcinoma | TFEC TCF3 CLSTN3 FRMPD2 WNK1 ADCY8 CDKL5 LRP2 FLCN DNAH8 EP300 ZNF292 | 1.14e-03 | 702 | 177 | 12 | C0009402 |
| Disease | hemangiopericytoma (is_marker_for) | 1.25e-03 | 9 | 177 | 2 | DOID:264 (is_marker_for) | |
| Disease | Abnormality of the face | 1.25e-03 | 9 | 177 | 2 | C4025871 | |
| Disease | phosphatidylcholine 36:0 measurement | 1.25e-03 | 9 | 177 | 2 | EFO_0021473 | |
| Disease | breast carcinoma | PRKD2 ATG10 ACO2 COX6A1 CNTNAP1 TACC2 SIN3A JMJD1C ADCY8 AHRR ATXN7 GLI2 NTN1 KLHDC7A BAHCC1 | 1.29e-03 | 1019 | 177 | 15 | EFO_0000305 |
| Disease | Mammary Carcinoma, Human | 1.33e-03 | 525 | 177 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.33e-03 | 525 | 177 | 10 | C1257931 | |
| Disease | Mammary Neoplasms | 1.37e-03 | 527 | 177 | 10 | C1458155 | |
| Disease | colorectal health | 1.39e-03 | 201 | 177 | 6 | EFO_0008460 | |
| Disease | hepatocyte growth factor-like protein measurement | 1.53e-03 | 38 | 177 | 3 | EFO_0008154 | |
| Disease | fetuin-B measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0008128 | |
| Disease | beta thalassemia (is_implicated_in) | 1.56e-03 | 10 | 177 | 2 | DOID:12241 (is_implicated_in) | |
| Disease | alpha wave measurement, electroencephalogram measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | Breast Carcinoma | 1.60e-03 | 538 | 177 | 10 | C0678222 | |
| Disease | reticulocyte count | FLNB NCOA6 HBS1L ARID3A BCL11A SLFN14 BIRC6 JMJD1C ADCY8 TFR2 CPEB4 LRP5 ADAM33 TMEM131 NOTCH4 | 1.65e-03 | 1045 | 177 | 15 | EFO_0007986 |
| Disease | neutrophil count | FLNB HNF1A HBS1L ERG MAML1 TEX14 KMT2E VWA7 JMJD1C TTLL12 EVI5 ATXN7 SH3D19 NLRC5 RERE NOTCH4 HTT ZNF292 | 1.71e-03 | 1382 | 177 | 18 | EFO_0004833 |
| Disease | immature reticulocyte measurement | 1.78e-03 | 40 | 177 | 3 | EFO_0803545 | |
| Disease | Sclerocystic Ovaries | 1.80e-03 | 144 | 177 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.80e-03 | 144 | 177 | 5 | C0032460 | |
| Disease | neutrophil count, eosinophil count | 1.86e-03 | 213 | 177 | 6 | EFO_0004833, EFO_0004842 | |
| Disease | platelet crit | TFEC HBS1L ERG AFF3 GPATCH8 SLFN14 PANK1 JMJD1C TFR2 TTLL12 RBPMS2 RERE CDH15 GP9 | 1.88e-03 | 952 | 177 | 14 | EFO_0007985 |
| Disease | gastrin-releasing peptide measurement | 1.90e-03 | 11 | 177 | 2 | EFO_0022000 | |
| Disease | alpha angle measurement | 1.90e-03 | 11 | 177 | 2 | EFO_0020071 | |
| Disease | eosinophil percentage of leukocytes | KLF12 HBS1L SOST ERG WNK1 JMJD1C PPP5C IFITM3 NLRC5 TMEM131 RERE ZNF292 | 1.90e-03 | 746 | 177 | 12 | EFO_0007991 |
| Disease | C-C motif chemokine 28 measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0020199 | |
| Disease | neutrophil count, basophil count | 2.39e-03 | 224 | 177 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | Neurodevelopmental Disorders | 2.41e-03 | 93 | 177 | 4 | C1535926 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 2.50e-03 | 45 | 177 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 2.50e-03 | 45 | 177 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | Malignant neoplasm of salivary gland | 2.50e-03 | 45 | 177 | 3 | C0220636 | |
| Disease | Craniofacial Abnormalities | 2.56e-03 | 156 | 177 | 5 | C0376634 | |
| Disease | visceral adipose tissue measurement | 2.59e-03 | 481 | 177 | 9 | EFO_0004765 | |
| Disease | Connective Tissue Diseases | 2.67e-03 | 13 | 177 | 2 | C0009782 | |
| Disease | brain cortex volume measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0010287 | |
| Disease | Salivary Gland Neoplasms | 2.83e-03 | 47 | 177 | 3 | C0036095 | |
| Disease | schizophrenia, anorexia nervosa | 3.01e-03 | 48 | 177 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | cannabis dependence measurement | 3.01e-03 | 48 | 177 | 3 | EFO_0008457 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 3.03e-03 | 99 | 177 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | revision of total hip arthroplasty | 3.11e-03 | 14 | 177 | 2 | EFO_0020973 | |
| Disease | T wave morphology measurement | 3.11e-03 | 14 | 177 | 2 | EFO_0008398 | |
| Disease | sulfate measurement | 3.11e-03 | 14 | 177 | 2 | EFO_0007864 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 3.19e-03 | 49 | 177 | 3 | EFO_0022256 | |
| Disease | hematocrit | SOX5 HNF1A HBS1L TRIM25 ERG AFF3 HID1 BCL11A PANK1 TFR2 LRP2 DLG4 NOTCH4 BAHCC1 | 3.24e-03 | 1011 | 177 | 14 | EFO_0004348 |
| Disease | aspartate aminotransferase measurement | WHRN PRKD2 FLNB HNF1A HBS1L ARHGEF19 BIRC6 SLC25A3 NLRC5 HRG ROBO1 PDE7B NOTCH4 | 3.29e-03 | 904 | 177 | 13 | EFO_0004736 |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.29e-03 | 239 | 177 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 3.38e-03 | 50 | 177 | 3 | C0023453 | |
| Disease | alcohol consumption measurement | SOX5 ATXN2L HNF1A ACO2 CHDH AFF3 HID1 BIRC6 ALMS1 FIBCD1 SCAF11 RERE EP300 HTT ZNF574 BAHCC1 | 3.42e-03 | 1242 | 177 | 16 | EFO_0007878 |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.49e-03 | 103 | 177 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | mean platelet volume | KLF12 DIS3L PCDHGA3 AFF3 FRYL SIN3A SLFN14 VWA7 JMJD1C DEGS1 CPEB4 PCDHGA8 HTT GP9 | 3.50e-03 | 1020 | 177 | 14 | EFO_0004584 |
| Disease | Proteinuria | 3.57e-03 | 15 | 177 | 2 | HP_0000093 | |
| Disease | B-cell acute lymphoblastic leukemia | 3.57e-03 | 15 | 177 | 2 | EFO_0000094 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.57e-03 | 243 | 177 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | smoking cessation | 3.59e-03 | 325 | 177 | 7 | EFO_0004319 | |
| Disease | COVID-19, mortality | 3.69e-03 | 170 | 177 | 5 | EFO_0004352, MONDO_0100096 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 3.74e-03 | 105 | 177 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 3.98e-03 | 173 | 177 | 5 | C0023467 | |
| Disease | Huntington's disease (is_marker_for) | 3.99e-03 | 53 | 177 | 3 | DOID:12858 (is_marker_for) | |
| Disease | Cardiovascular Abnormalities | 4.06e-03 | 16 | 177 | 2 | C0243050 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSHVQNGAPFPAAFP | 226 | Q86YH2 | |
| KPHINGPFTPDLAHP | 346 | Q99798 | |
| HFPQRSLQHQLPQPG | 486 | A9YTQ3 | |
| NPHKPPILIQNESHG | 476 | P51826 | |
| PNHHAPQLSGDSALP | 76 | P40145 | |
| PPLQHHGQLAQPGAL | 731 | Q09472 | |
| HPALHQNLPPGFPAS | 841 | Q9P281 | |
| HPLVPNQGDHSAHLP | 336 | Q4VCS5 | |
| HPINFGGPHNFVQVP | 361 | P78357 | |
| HQEQHNIPFPCLLAG | 556 | Q9NR09 | |
| SQQFLHRGHQPPPEM | 816 | Q9BQT9 | |
| VNPVNDPPHIIFPHG | 546 | Q6UVK1 | |
| EPLPPHEVPGHQSVF | 701 | Q9P2I0 | |
| NSVDPFVAHPQDPHH | 76 | O14639 | |
| PAHGQSFIQIPHEAF | 401 | Q6QNK2 | |
| DFHGIAQALQPHPPE | 391 | P11308 | |
| PSIFHQQALPGTHIP | 1151 | Q8TCU4 | |
| QLLVALHHPEGPEPA | 261 | Q96PS8 | |
| VPALFPHPQHAELPG | 91 | Q3C1V8 | |
| HYGPDGQPVVLAPNH | 96 | Q9BZ11 | |
| ILGRPPFTPNHQQHN | 6 | Q6PIY7 | |
| QEHPILGQPFFVLHP | 151 | Q9H0Y0 | |
| PPNPALAGFRALAQH | 221 | Q8N1D0 | |
| NHVVNCLQPHPFDPI | 761 | Q58WW2 | |
| DLHNLAPGTHPPFLT | 221 | Q9NZA1 | |
| AAADIPQPAFRHQGP | 206 | A6NDY2 | |
| QHAHPFFFTIPQNLP | 111 | P32121 | |
| HFFNVPEPDGHIISP | 351 | Q9P241 | |
| FNEADFIPHHLAPRP | 1016 | Q9UKP4 | |
| PSPVQHQAGQAPHLG | 891 | Q8WWM7 | |
| APQPVFLSHGVPLHQ | 351 | Q6IQ32 | |
| FLSHGVPLHQSVNPP | 356 | Q6IQ32 | |
| PGVPHPDIQFHFLPS | 391 | Q8NE62 | |
| KAHPPAFLTDLNNPH | 101 | O95631 | |
| PNPSNVHPALGAHFI | 121 | Q6ZRY4 | |
| HVADINDNPPTFPHA | 441 | Q9Y5G5 | |
| AAADIPQPAFRHQGP | 206 | A6NKC0 | |
| NGHSFHTPQKGPPIE | 186 | Q9Y450 | |
| PPGTAHHPVAVCQQE | 16 | Q8IW93 | |
| EAHHFPGPLLVELAN | 96 | Q9NVI1 | |
| IVAQPPPQATNGHAH | 766 | Q92585 | |
| ADHLAQPQPQGHLAP | 11 | Q5SY85 | |
| AELSNPHAGIFPHPS | 616 | Q5VUB5 | |
| PHAGIFPHPSSQIQP | 621 | Q5VUB5 | |
| ANPFNTPHLQLVHDG | 11 | Q00325 | |
| NTPSHQLQVPEHPFL | 2496 | P46531 | |
| PQEHENINGVPPHLG | 246 | P04196 | |
| NFLGLSPHVQIPPHV | 416 | Q8NFG4 | |
| NSAAGFPHAPPQAHA | 56 | P13378 | |
| PPSFLGQEHQAPGHS | 346 | Q8IU57 | |
| DLQHPHQHPFEPGKF | 186 | Q2TV78 | |
| EHEVAVLGAPHNPAP | 26 | Q01628 | |
| IIELAAHFQPPGPQA | 486 | O95671 | |
| AHFQPPGPQAVQIHF | 491 | O95671 | |
| ANHISPFLSQHPFPL | 726 | Q15652 | |
| QPGPAFPHRATHLDP | 241 | Q86X51 | |
| PHVPLNFIAPGGSQH | 1431 | O75197 | |
| PGHTGPVNVVEFHPN | 186 | Q9BVA0 | |
| CPSQPPLHGIHIADN | 221 | Q9H165 | |
| PLHGIHIADNNPFNL | 226 | Q9H165 | |
| HPIFSGQDLQHPPSH | 1486 | Q9UKJ3 | |
| GHHIPKSPFEVQVGP | 531 | O75369 | |
| KSVQPDPASPIHGHN | 886 | A6NKB5 | |
| DQNDHAPVLVHPAPA | 601 | O95206 | |
| AAHDVDHPGVNQPFL | 211 | Q9NP56 | |
| FSGQPPFDGIHIVNH | 716 | O60447 | |
| PSLDNPEVFGLHPNA | 4171 | Q96JB1 | |
| TQHGVANGASHPPPL | 661 | O94915 | |
| PHPGFNNSLPNKDHR | 126 | Q9UBX7 | |
| PGHFLPSQNPTIHHQ | 1606 | Q8IZD2 | |
| FQQHSANPPHEFQPV | 221 | O94854 | |
| VILQDAPSAPGHAPH | 511 | Q9BZL6 | |
| PPFNAAGHHQNEAPA | 181 | O60337 | |
| HVPSQDPAGIQHLQP | 566 | P20823 | |
| AAQGVPQHLLPPFHA | 46 | P10070 | |
| PHPVNQVTFLAHPQK | 421 | O95163 | |
| LPEHHAAAPNGLPGF | 256 | Q99958 | |
| LHLDPENHSPPFQTI | 2401 | P98164 | |
| GQLHDPQPYPQHAIQ | 966 | Q9NQV6 | |
| PSFANVHKDPNPAHQ | 506 | A2A3K4 | |
| NQAHPPKGRHVFATP | 1301 | P23471 | |
| HTLFHNPHVNPLPTG | 91 | P12074 | |
| LAAPAHQPQPAAQLH | 86 | Q05925 | |
| HQNPHGVIPSESKPF | 426 | O15265 | |
| SGQPHAFHQVYVPPI | 166 | Q86WI3 | |
| AAHQPHIGLAPAAFV | 411 | Q14671 | |
| HVIDINDNPPTFPHL | 441 | Q9Y5H0 | |
| IQQQSHPSGSLAPPH | 226 | Q14686 | |
| QHPQTIEQGHDPIFP | 226 | Q9P2D7 | |
| NSLQSVPPGAFDHLP | 61 | P14770 | |
| HVQLAFFPPGTVHPL | 311 | P07199 | |
| QAPPPSHIPFHQGVQ | 126 | B1AJZ9 | |
| QQLPAVHHVFQPELP | 2181 | P42858 | |
| VHHVFQPELPAEPAA | 2186 | P42858 | |
| HFIHVKPPQLPAGHT | 126 | P07099 | |
| SAGFHVPPHQPLQLC | 116 | Q68DX3 | |
| LRQHPPPHQEFFSEL | 706 | Q8TF46 | |
| SNKHPALAEINPNHP | 551 | Q8NBF6 | |
| PAFATNHAPVNAKPH | 91 | Q6ZUJ4 | |
| PPQGSPQDQHHFLRS | 71 | Q96RY5 | |
| PQVHHSQPQPFAGTA | 741 | Q5VT06 | |
| EHHDFPNIPGKSLPL | 261 | O15121 | |
| PPVHIHPAFARQAAQ | 216 | Q92949 | |
| PLEHSPAHLPNQANS | 21 | P78352 | |
| SPFNLDEHHPRLFPG | 21 | O75578 | |
| VLFLNHAHAPGTAPP | 51 | Q8N539 | |
| QLEPPHCHYVAPLQG | 201 | Q5VTJ3 | |
| HVQPVAGTNFFHIPL | 406 | Q5VTJ3 | |
| GGQQFLHIIHPVPPS | 156 | Q9Y4X4 | |
| NKSAFPVRFHPHLQP | 16 | Q17RY0 | |
| LQPPHSFFGAQHRDP | 141 | Q04741 | |
| DLQHPHQHPFEPGKF | 216 | P26927 | |
| NLHFHSPNPEIPALL | 356 | P49327 | |
| NPRFHGLRFPAVNHP | 241 | O76039 | |
| PFNIHPQLPLHLHTG | 1246 | Q99590 | |
| GLHLHIPNIFPANPA | 341 | Q8IY34 | |
| LAHHQVQPFAPHGPQ | 961 | Q9Y467 | |
| VQPFAPHGPQNIAAL | 966 | Q9Y467 | |
| ADLQQHLFPVPPGHL | 391 | Q68D06 | |
| TDEDLPPHGAPFHFQ | 506 | P55291 | |
| VIHPKNPHAPTIHFN | 246 | P36551 | |
| LLQQEAVAPHPVGHP | 136 | Q5FWE3 | |
| HLESHPPGPFEVNAE | 271 | O75309 | |
| AAAVNGLLHNGFHPP | 161 | Q8TE04 | |
| GNGPPHLAHPNLDTF | 21 | Q96CV9 | |
| HEDQGLQAPAPPHAA | 426 | Q9NSD7 | |
| AAHHPPFAELLEPGS | 136 | Q9BQG1 | |
| NHFQHPLPPQGGLPD | 2261 | Q5T011 | |
| LQQAVPVDLFPHTPH | 481 | Q96GJ1 | |
| FQIHHADVNGLPPPS | 706 | P0C7P3 | |
| AFSQHHIDELPPPSQ | 1321 | Q8IWB6 | |
| GAPHAVVLHDFPAEQ | 496 | Q5HYK7 | |
| PVPNGNLHQHDPQDL | 146 | P0DPB3 | |
| LSHGFPPIHQPLLAE | 86 | P28069 | |
| PQFHQFTAVPHPNVK | 471 | P53041 | |
| FHQLANLPTDPPTIH | 561 | Q8IV36 | |
| GQVVQSHAHPAPPVA | 96 | Q96ST3 | |
| HEHPDLIVGFNAFLP | 91 | O75182 | |
| DDPPNVHIIGNLPFS | 131 | Q8WVM0 | |
| DAHLALVNQHPIGPF | 666 | Q9P202 | |
| PHPFASFHPGLNPLE | 1361 | Q9P2R6 | |
| QDPLHQGSAGPVHPL | 1441 | Q9P2R6 | |
| NGGRPPHHPFETKDV | 61 | Q9BQB4 | |
| AVHPHAGTAPPANQL | 1431 | Q99466 | |
| LQHPPPSVEHTGGAN | 336 | Q9NPE6 | |
| HEPQPPHSVLKFLQD | 606 | Q9NZQ3 | |
| QNGAHATGHPPQRFP | 71 | O94855 | |
| RHGFPHQPTALAFDP | 66 | Q9Y2K9 | |
| HESSHEEPLQPFPQL | 566 | Q8TE77 | |
| GGAAHVAPQLQPPDH | 206 | Q99856 | |
| RHPTPHQAAGQPFKF | 6 | Q04724 | |
| PLPAHLQQAFHDGGQ | 1321 | Q6ZU65 | |
| FQHLHPIVVQAAFPP | 486 | P51449 | |
| GHEQHSPLVAPPAAL | 261 | O15027 | |
| HENPGLAPNQGLHEF | 711 | A0A1B0GUW6 | |
| VLSAPHPGLSEAHNP | 636 | P15923 | |
| AHPPLLVLNSFGPHG | 136 | Q9NQ55 | |
| AVPHPQHPGDFGNFA | 136 | P08294 | |
| TPLQDPQGLFPDLHH | 846 | Q9H6E5 | |
| LHVQVAPALPAPAHQ | 426 | A6NE52 | |
| LQPHFDSPAFQDHPL | 131 | Q14258 | |
| LHNGFRGSDLPPDPH | 91 | Q92610 | |
| PADFLEHQATHFPAP | 226 | Q6ZN55 | |
| FSPIINIHNPHSEPL | 226 | Q92545 | |
| SAQLQHVSPPIFPAH | 1181 | O60281 | |
| QGAHIVLEVPPYHNP | 656 | Q12968 | |
| HLHNAIPGFPVPKFD | 2416 | Q9P273 | |
| LFNPHTLHPLDPEEN | 371 | Q96LQ0 | |
| RQEFHAGVPHPPQGE | 771 | O95359 | |
| PQFIQLDAHGNPVSP | 866 | Q9Y6N7 | |
| SQPQGAPAEPHIHVL | 1576 | Q9BZZ2 | |
| AHHLVPGPPDTPAQQ | 11 | Q9P283 | |
| LHAAQHFPNLPTAPG | 71 | Q6UXP9 | |
| LRGNPQAITPEPFHH | 226 | Q96GW9 | |
| SIQHVYGAQHPPFDP | 21 | Q8WUA7 | |
| PLDINPVVHPHGHIF | 291 | Q14166 | |
| NGNKSDQAHPPIHPT | 406 | Q13472 | |
| APHVPNQPSEAAAHF | 1226 | A7E2V4 | |
| DEPAPNQVTFHLPLH | 621 | Q6ZT12 | |
| PHPFLPNVDFVGGLH | 266 | P36537 | |
| DVHFEHPAPALAPNE | 291 | Q7RTT9 | |
| GLPAFHLPLHVSFPN | 46 | P35711 | |
| QPAVPSGGPLVQHAH | 16 | O14948 | |
| VPVHSGAHFLPVGQP | 816 | Q9H4A3 | |
| PGDPQPHFSHVILRG | 646 | Q9Y334 | |
| HYVGLQFPDPAHPNT | 196 | Q9UP52 | |
| QAAGASPHPHNAFVP | 1241 | Q702N8 | |
| QPPEFLLVHDSGPDH | 2386 | P18583 | |
| PVQKALDLPFPSHHQ | 401 | Q12836 | |
| VLHRQPHLQPCNFGP | 41 | Q9UI25 | |
| TEQGAPHFLHPVLPH | 656 | A6NNM8 | |
| LAHEGSSVPHNPNKP | 3656 | Q5THJ4 |